Inhaltsseite: Home

ZKB Autocallable Barrier Reverse Convertible on worst of
Bristol-Myers Squibb Co/Gilead Sciences Inc/Johnson & Johnson

ISIN: CH1329108612 Security: 132910861 Symbol: n.a. Life cycle
Secondary market

Bid Price 98.20%

Ask Price n.a.

Currency qCHF

Exchange ZKB

Volume 300'000.00

Volume n.a.

Date/time (realtime) 04.12.2024 05:35:39

Sell Buy 

Underlying value

UnderlyingPriceInitial fixingCurr.CapDistance to capBarrierDistance to barrierRatio
Bristol Myers A58.44551.654USD51.65
(100.00%)
11.51%36.158
(70.00%)
38.06%n.a.
Gilead Sciences A91.4573.8812USD73.88
(100.00%)
19.12%51.717
(70.00%)
43.38%n.a.
Johnson & Johnson A150.26161.7065USD161.71
(100.00%)
-7.29%113.195
(70.00%)
24.90%n.a.

Reference data

ISIN CH1329108612
Security 132910861
Symbol n.a.
Currency qCHF
Currency hedging Yes
Nominal amount 1'000.00
Barrier level observation continuous
Maximum repayment n.a.

Coupon

Coupon (Coupon p.a.)BMY + 6.97%
Coupon paymentguaranteed

Life cycle

Issue price100.00%
Initial fixing date26.02.2024
Payment day04.03.2024
First trading day04.03.2024
Last trading day26.08.2025
Final fixing day26.08.2025
Redemption date02.09.2025
Redemption typeCash Settlement
Early redemptionYes
Next observation date24.02.2025
Residual term264
Issue amount300'000.00

Price data

Price status flat Marchzins
Exchange ZKB
Trade time 09:15 - 17:15 (CET)
Round lot CHF 1'000.00
Performance of underlying since issue -6.79%

Product type

SSPA derivative category Yield enhancement
SSPA code Barrier reverse convertible (1230)

Legal parties

Issuer Zürcher Kantonalbank Finance (Guernsey) Ltd
Keep-Well Agreement with Zürcher Kantonalbank, Zürich
Issuer rating
Lead manager Zürcher Kantonalbank, Zürich
Payment, execution and calculation agent Zürcher Kantonalbank, Zürich

Tax aspects (Private investor tax domicile Switzerland)

Income taxYes
Withholding taxNo
Stamp duty payable in the secondary marketYes
Stamp duty payable upon delivery of the securitiesNo
SIX Telekurs EU tax classification code (out of scope)
Internal Rate of Return1.22%
Cash value of fixed income investment upon issue98.21%
Cash value of fixed income investment upon redemption100.00%

Sales restrictions

USA, US persons, Guernsey, EEA, GB

Redemption

Redemption date02.09.2025
Redemption amount
Redemption currencyn.a.
Underlyingn.a.
Physical delivery-

Ajax loading